徵求113年度整合性醫藥衛生科技研究計畫

國家衛生研究院為整合國內醫藥衛生相關研究工作及成果,提升我國醫藥衛生研究水準,即日起公開徵求113年度整合性醫藥衛生科技研究計畫,徵求之研究重點強調問題及任務導向,並希冀能與本院院內研究相輔相成,以有效解決國人重要醫藥衛生問題。

I. 徵求計畫類型
1. 個人型計畫:包括創新研究計畫(Innovative Research Grant, IRG)及研究發展獎助計畫(Career Development Grant, CDG),研究重點概分為11項,請選擇符合之重點撰寫計畫書。
(1) Cancer research
(2) Cardiovascular and metabolic disorders
(3) Infectious diseases
(4) Mental/neurological disorders and addiction
(5) Immunity and inflammation
(6) Aging
(7) Biomedical engineering
(8) Health policy and social welfare
(9) Environmental health
(10) Indigenous health
(11) others
2. 統合型計畫:臺灣醫衛重要主題研究計畫(Thematic Research Grant for Important Health Issues of Taiwan, TRG),以二年徵求一次為原則,本次徵求重點如下,請務必詳閱申請作業手冊之徵求重點內容後,再撰寫計畫書。
• Integrated patient-oriented study on cardiovascular diseases
(1) Objective:
♦The aim of this call for proposal is to reduce the mortality rate caused by cardiovascular diseases in Taiwan.
(2) Background:
♦Cardiovascular diseases have high mortality rate, which are also the main cause of premature death. A lot of efforts and resources have been put to improve the situation in Taiwan, but the progress is incremental in comparison with other developed countries. Thus, new approaches or strategies are needed to improve patient outcomes.
(3) Research Priority:
♦ The study must be patient-oriented and focus on ischaemic heart disease, myocardial infarction or heart failure.
♦ Research proposal should at least include, but not limited to, 3 of the following 4 research dimensions: 1) basic medical research; 2) translational research; 3) clinical study; 4) epidemiological research. A feasible and achievable goal by the end of the funding period and a timeline of deliverables at the end of each year should also be clearly defined.
♦ The applicants can tackle the objective from different aspects (such as prevention, diagnosis, intervention therapy, integrated outpatient care, etc.) and with different approaches (such as mechanism elucidation, risk factor identification and management, biomarker/ therapeutics/ medical device development, cost-effectiveness analysis of existing intervention measures, etc.)
♦ Multi-medical center collaborations are encouraged.

II. 線上申請截止期限(https://erad.nhri.edu.tw/;逾時恕不受理)
1. 計畫申請書及相關附件:2023年3月31日(星期五)下午4時正
2. 申請機構公函請於2023年4月12日(星期三)下午4時正前送達本院

III. 申請作業手冊(完整手冊下載:https://erad.nhri.edu.tw/assets/manual.pdf
欲索取紙本手冊者請傳真、email或電洽

IV. 有關申請作業之疑義,請洽本院學術發展處
1. 地址:35053苗栗縣竹南鎮科研路35號
2. 電話:(037) 206-166疑義查詢轉33306~07、33309、33311~13、33315~16
3. 傳真:(037) 580-762
4. e-mail:extra@nhri.edu.tw
5. 網址:https://pd.nhri.edu.tw/category/news/

 

文/圖:學術發展處

 

 

 

 

 

 

 

 

 

 

 

國家衛生研究院為整合國內醫藥衛生相關研究工作及成果,提升我國醫藥衛生研究水準,即日起公開徵求113年度整合性醫藥衛生科技研究計畫,徵求之研究重點強調問題及任務導向,並希冀能與本院院內研究相輔相成,以有效解決國人重要醫藥衛生問題。

I. 徵求計畫類型
1. 個人型計畫:包括創新研究計畫(Innovative Research Grant, IRG)及研究發展獎助計畫(Career Development Grant, CDG),研究重點概分為11項,請選擇符合之重點撰寫計畫書。
(1) Cancer research
(2) Cardiovascular and metabolic disorders
(3) Infectious diseases
(4) Mental/neurological disorders and addiction
(5) Immunity and inflammation
(6) Aging
(7) Biomedical engineering
(8) Health policy and social welfare
(9) Environmental health
(10) Indigenous health
(11) others
2. 統合型計畫:臺灣醫衛重要主題研究計畫(Thematic Research Grant for Important Health Issues of Taiwan, TRG),以二年徵求一次為原則,本次徵求重點如下,請務必詳閱申請作業手冊之徵求重點內容後,再撰寫計畫書。
 Integrated patient-oriented study on cardiovascular diseases
(1) Objective:
 The aim of this call for proposal is to reduce the mortality rate caused by cardiovascular diseases in Taiwan.
(2) Background:
 Cardiovascular diseases have high mortality rate, which are also the main cause of premature death. A lot of efforts and resources have been put to improve the situation in Taiwan, but the progress is incremental in comparison with other developed countries. Thus, new approaches or strategies are needed to improve patient outcomes.
(3) Research Priority:
 The study must be patient-oriented and focus on ischaemic heart disease, myocardial infarction or heart failure.
 Research proposal should at least include, but not limited to, 3 of the following 4 research dimensions: 1) basic medical research; 2) translational research; 3) clinical study; 4) epidemiological research. A feasible and achievable goal by the end of the funding period and a timeline of deliverables at the end of each year should also be clearly defined.
 The applicants can tackle the objective from different aspects (such as prevention, diagnosis, intervention therapy, integrated outpatient care, etc.) and with different approaches (such as mechanism elucidation, risk factor identification and management, biomarker/ therapeutics/ medical device development, cost-effectiveness analysis of existing intervention measures, etc.)
 Multi-medical center collaborations are encouraged.

II. 線上申請截止期限(https://erad.nhri.edu.tw/;逾時恕不受理)
1. 計畫申請書及相關附件:2023年3月31日(星期五)下午4時正
2. 申請機構公函請於2023年4月12日(星期三)下午4時正前送達本院

III. 申請作業手冊(完整手冊下載:https://erad.nhri.edu.tw/assets/manual.pdf)
欲索取紙本手冊者請傳真、email或電洽

IV. 有關申請作業之疑義,請洽本院學術發展處
1. 地址:35053苗栗縣竹南鎮科研路35號
2. 電話:(037) 206-166疑義查詢轉33306~07、33309、33311~13、33315~16
3. 傳真:(037) 580-762
4. e-mail:extra@nhri.edu.tw
5. 網址:https://pd.nhri.edu.tw/category/news/

《文/圖:學術發展處》

Comments are closed.